Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Poerio
Pancreatic Enzyme Elevation in Chronic Myeloid Leukemia Patients Treated With Nilotinib After Imatinib Failure
Haematologica
Hematology
Related publications
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Satisfaction With Information on Nilotinib Treatment in Chronic Myeloid Leukemia Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Prognostic Value of Tumor Clones Early Reducation in Patients With Chronic Myeloid Leukemia on Nilotinib Treatment Who Failed Imatinib
Hematology & blood transfusion: interdepartamental collection
Prognostic Factors Associated With a Stable MR4.5 Achievement in Chronic Myeloid Leukemia Patients Treated With Imatinib
Oncotarget
Oncology
Nilotinib vs Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 3-Year Follow-Up
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Rates of Peripheral Arterial Occlusive Disease in Patients With Chronic Myeloid Leukemia in the Chronic Phase Treated With Imatinib, Nilotinib, or Non-Tyrosine Kinase Therapy: A Retrospective Cohort Analysis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
